Is Needham Considered MM?
Thinking of applying to their open listings, curious about what people's opinions are about the bank.
Interested in their healthcare and tech practice.
Thinking of applying to their open listings, curious about what people's opinions are about the bank.
Interested in their healthcare and tech practice.
| +186 | UBS Accused of Favoring H-1B Workers While Cutting U.S.-Born Employees | 46 | 4h |
| +83 | IB Energy Drink Tier List / Ranking | 57 | 5h |
| +76 | PJT M&A Group Selection 2026 | 13 | 17h |
| +55 | ONLY THESE BANKS OR YOU STRUCK OUT | 15 | 3m |
| +36 | Quick Thoughts on CVC AI Sale Process | 7 | 3d |
| +34 | Feedback for internship first desk at IBD BB - personal fit, "don't be too confident" | 23 | 1d |
| +28 | Does BofA still pay its associates rat pellets? | 14 | 7h |
| +18 | What happened to Greenhill | 8 | 3d |
| +18 | Updated JPM Group Rankings | 30 | 8h |
| +18 | VP Deal Origination Credit | 2 | 15h |
Career Resources
Below MM. barley a bank. far right co manager on $75mm life sci FOs
LMM
No
Regional or LMM. MM would be Truist / Lincoln / Stifel etc and UMM would be Baird / Blair / HL / HW. Needham doesn’t compete with any of these.
why would those 4 be considered UMM? that implies jeff/gugg/roths are something above UMM
How are the HC and Tech groups in 2026?
Would not give too much weight to the comments above (perhaps just outdated). Although the firm is smaller and more “boutique-y” in total size (~200 employees across all offices), they definitely punch above their weight class in terms of output.
On the ECM side, they made it into the SpaceX and SK Hynix IPOs, of which many of the firms above and other competitors (TD Cowen, Jefferies, etc.) did not. Though these are typically smaller passive roles on the larger mega deals, they are frequently lead-left / active book on smaller offerings.
M&A is office/sector dependent, though overall not a volume shop like HL or Lincoln by any means. Boston and SF have recently closed numerous solidly 9-figure semiconductor / quantum deals, though majority otherwise can be considered MM/LMM M&A ($50M - $150M). Tech is much stronger than healthcare as a product of greater headcount / MDs on the tech side.
Firm is coming off a strong year in 2025 with extremely solid momentum in 2026. Overall it’s a solid sector-focused MM shop that often flies under the radar but has strong senior tenure and solid junior culture. Feel like there’s not a lot on here about the firm and saw the thread pop up so figured I’d chime in.
Source: I work here
Ut sunt nobis velit suscipit. Minima sequi ea voluptatem vero veritatis ab. Iste dolor consequuntur quod cupiditate et. Debitis consequuntur mollitia esse omnis deleniti. Animi aut voluptates quasi atque beatae.
Rem architecto quae asperiores quaerat placeat laboriosam ducimus. Repellat ut sint aut sint. Fuga reiciendis quibusdam illo temporibus odio non. Nobis necessitatibus necessitatibus hic voluptas.
Ut cumque quis molestias optio saepe soluta velit. Dolorum nostrum vitae aperiam explicabo perferendis in numquam.
Aut qui corporis libero delectus eum ut. Iure eligendi reiciendis repellendus. Ratione sed sint autem recusandae tempora et. Non quis ut et impedit eius. Est blanditiis id fugit ea qui. Ex debitis sequi nihil quaerat adipisci. Est fugiat illo ratione quibusdam laborum minus vel.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...